跳至主要内容
临床试验/NCT03798327
NCT03798327已完成不适用

Video-Assisted Palliative Care Intervention for Patients With Advanced Dementia at Home

Icahn School of Medicine at Mount Sinai4 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2018年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
4
主要终点
Number of Patients Who Completed the Symptom Management at the End of Life for Dementia Scale (SM-EOLD)

研究概览

简要总结

The proposed project is a randomized controlled trial of a new home-based palliative care program for adults with advanced dementia and their caregivers within the Mount Sinai Health System. Potential subjects will be identified from Mount Sinai records or referred by a Mount Sinai healthcare provider. Patients will only be approached after authorization by their Mount Sinai physician. Participants who consent to enrollment will be randomized to receive the intervention (home-based palliative care program) or usual care (with their nominated Mount Sinai physician). Patients will be enrolled in the study for 6 months.

Effectiveness of the intervention will be determined through assessment of patient and caregiver reported outcomes and abstraction of data from medical records and administrative claims. Impact on the following parameters will be measured: (i) Patient symptoms, quality of life, satisfaction with care, documentation of advanced directives, receipt of care consistent with preferences (ii) Caregiver burden, satisfaction with care, and depression (iii) Healthcare utilization and costs of care.

详细描述

The objective of this randomized controlled trial is to study the impact of a new home based palliative care program on patients' symptoms, quality of life, satisfaction with care, completion of advance care planning documentation and receipt of care consistent with preferences. In addition, the study will examine the impact of this model of care on patient healthcare utilization, including hospitalization, emergency department utilization, and hospice use prior to death. The trial will also include patients' caregivers, in order to examine the impact of the intervention on caregiver burden and prevalence of depression.

Patients randomized to the intervention will be scheduled for an intake visit. This visit will be undertaken by the team's registered nurse and/or social worker, together with a community health worker, and other team members (advanced practice nurse, MD), depending on patients' needs. Visits will combine a combination of video-teleconferencing technology and in person visits. Following this visit, and in conjunction with the nurse practitioner and/or MD, a care plan will be developed to address areas of clinical need highlighted during the intake visit.

Patients in the intervention arm will receive ongoing monitoring and input (telephone-based, video-based, and in-person) from members of the clinical team, dependent on their identified needs. Patients' cases will be discussed at the weekly IDT meeting, as appropriate to the level of clinical need. Patients and caregivers will be provided with access to a 24 hour telephone line, staffed by a Mount Sinai based physician, which acts as an advice line out of hours. These physicians will be able to provide advice to patients and caregivers.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Single (Outcomes Assessor)

盲法说明

Single blind control

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Presence of advanced dementia
  • Subject has a Mount Sinai physician who authorizes their participation in the study and receipt of the program
  • Subject is resident in Manhattan outside of a long term care facility and is not receiving hospice
  • Subject has evidence of capacity to benefit from enrollment in palliative care program
  • Subject is conversant in English or Spanish
  • Subject has capacity to consent or has a caregiver who can provide consent for the patient

排除标准

  • Subject has no usual physician within Mount Sinai
  • Subject's usual physician doesn't provide authorization to patient participation
  • Subject resident outside of Manhattan or in long term care facility or receiving hospice
  • Subject is not conversant in English or Spanish
  • Subject cannot provide consent or has no caregiver who can provide consent

结局指标

主要结局

Number of Patients Who Completed the Symptom Management at the End of Life for Dementia Scale (SM-EOLD)

时间窗: Baseline, 3 months, 6 months

Number of Patients who completed the SM-EOLD Assessment Scale: Symptom Management at the End of Life for Dementia - Likert scale, 9 items, each 0-5, (45 total possible score) higher is worse symptoms

次要结局

  • Preference Consistent Care(6 months)
  • Number of Patients Who Completed the McGill Quality of Life Assessment(Baseline, 3 months, 6 months)
  • Number of Complete of Advance Directives(6 months)
  • Number of Caregivers Who Completed the Caregiver Zaria Burden Inventory(Baseline, 3 months, 6 months)
  • Number of Caregivers Who Completed the FAMCARE-10 Assessment(Baseline, 3 months, 6 months)
  • Number of Caregivers Who Completed the Patient Health Questionnaire (PHQ-9)(Baseline, 3 months, 6 months)
  • Mean Change in Number of Hospital Admissions(Baseline and 6 months)
  • Hospital Length of Stay(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nathan Goldstein

Professor, Geriatrics and Palliative Medicine

Icahn School of Medicine at Mount Sinai

研究点 (4)

Loading locations...

相似试验